MPT — Medical Properties Trust, Inc. stock price, charts and financials

NYSE·Real Estate·REIT - Healthcare Facilities·USA

Latest market price

4.11

-0.60-12.66%

Overview Short InterestFilings

MPTQT44Medical Properties Trust, Inc.·NYSE

Overview Short InterestFilings

4.11-12.66%

Loading chart...

Signal & projected range

Short-squeeze setupHistorical pattern — not a prediction

Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)

Horizon

Unlock the projected rangeSee where this setup landed historically — with Premium.

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Premium shows the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands ofhistorical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →

MPW+1.52%$5.36 NHI-1.25%$74.36 LTC-1.46%$39.27 DHC-4.76%$8.40 SILA+0.00%$30.36 SBRA-1.71%$20.68 HR-1.18%$19.73 CTRE-2.11%$40.35

Snapshot

Index	-	P/E	-	EPS (ttm)	-0.21	Insider Own	2.85%	Shs Outstand	598.10M	Perf Week	1.51%

Market Cap	2.81B	Forward P/E	39.47	EPS next Y	0.12	Insider Trans	0.00%	Shs Float	490.65M	Perf Month	2.17%

Enterprise Value	12.15B	PEG	-	EPS next Q	-	Inst Own	-	Short Float	28.17%	Perf Quarter	-11.82%

Income	-125.94M	P/S	2.81	EPS this Y	163.31%	Inst Trans	-	Short Ratio	23.40	Perf Half Y	-10.98%

Sales	1.00B	P/B	0.62	EPS next Y	-10.42%	ROA	-0.85%	Short Interest	138.23M	Perf YTD	-6.00%

Book/sh	-	P/C	13.00	EPS next 5Y	-	ROE	-2.70%	52W High	5.65 -27.36%	Perf Year	12.98%

Cash/sh	-	P/FCF	13.01	EPS past 3/5Y	-	ROIC	4.12%	52W Low	3.45 18.99%	Perf 3Y	-52.33%

Dividend Est.	0.36 (8.77%)	EV/EBITDA	12.83	Sales past 3/5Y	-14.28% -4.89%	Gross Margin	96.07%	Volatility	2.38% 2.68%	Perf 5Y	-77.65%

Dividend TTM	0.35 (8.53%)	EV/Sales	12.15	EPS Y/Y TTM	94.78%	Oper. Margin	56.95%	ATR (14)	0.13	Perf 10Y	-69.85%

Dividend Ex-Date	Jun 18, 2026	Quick Ratio	11.12	Sales Y/Y TTM	0.40%	Profit Margin	-12.59%	RSI (14)	49.89	Recom	2.75

Dividend Gr. 3/5Y	-34.23% -21.11%	Current Ratio	11.12	EPS Q/Q	-61.29%	SMA20	-0.34%	Beta	1.45	Target Price	11.27

Payout	-159.15%	Debt/Eq	2.15	Sales Q/Q	12.50%	SMA50	-0.77%	Rel Volume	0.92	Prev Close	4.70

Employees	121	LT Debt/Eq	1.99	Earnings	Aug 10	SMA200	-6.98%	Avg Volume	5.66M	Price	4.11

IPO Date	Jul 07, 2005	Option/Short	Yes / Yes	EPS/Sales Surpr.	97.09% 4.32%	Net Debt/EBITDA	9.86	Volume	5,174,857	Change	-12.66%

Analyst Ratings

Date	Action	Analyst	Rating	Target
Feb-03-26	Initiated	Maxim	Buy	$8.00
Nov-25-25	Reiterated	Wells Fargo	Underweight	$7.50 → $5.00
Mar-12-25	Upgrade	Exane BNP Paribas	Neutral → Outperform
Mar-11-25	Reiterated	BNP Paribas		$4.00 → $9.00
Sep-13-24	Upgrade	Colliers Securities	Neutral → Buy	$6.50
Sep-13-24	Reiterated	Truist Securities	Hold	$8.00 → $6.00
Sep-12-24	Reiterated	Mizuho Securities	Neutral	$7.00
Aug-02-24	Reiterated	Wells Fargo	Underweight	$7.50
Aug-02-24	Reiterated	Truist Financial	Hold	$5.00 → $8.00
Jul-02-24	Downgrade	Exane BNP Paribas	Outperform → Neutral

Latest News

Today

Today10:30AM

Medical Properties (MPT) Q2 FFO Miss Estimateszacks.com

Aug-07-26

Aug-07-2609:15AM

Medical Properties Trust: Mr. Market, You're Too Bearishseekingalpha.com

Jul-29-26

Jul-29-2608:00AM

MPT Announces Second Quarter 2026 Financial Results Conference Call and Webcastbusinesswire.com

Jul-28-26

Jul-28-2609:15AM

2 Plunging 6-12% Yields: Only One Belongs In A Retirement PortfolioSeekingAlpha

Jul-20-26

Jul-20-2607:15AM

Sell Alert: 3 REITs Facing Likely Dividend CutsSeekingAlpha

Jul-12-26

Jul-12-2609:30AM

My 4 Worst REIT Picks: Lessons Learned The Hard WaySeekingAlpha

Jul-09-26

Jul-09-2606:03PM

Why I'm Buying Healthcare REITs Before Wall Street DoesSeekingAlpha

Jul-08-26

Jul-08-2608:00AM

Medical Properties Trust Announces Infracore Swiss Listingbusinesswire.com

Jun-23-26

Jun-23-2604:42PM

Medical Properties Trust's Tenant And Balance Sheet Risks Remain: A Contrarian Dividend StorySeekingAlpha

Jun-22-26

Jun-22-2608:13AM

Medical Properties: Strong Recovery PotentialSeekingAlpha

Jun-19-26

Jun-19-2610:45AM

U.S. Equity REIT Average Short Interest Edges Higher In MaySeekingAlpha

Jun-18-26

Jun-18-2609:57AM

RBC Capital Maintains Sector Perform on Medical Properties Trust, Lowers Price Target to $4.5Benzinga

Jun-17-26

Jun-17-2612:53PM

Bloom Energy and M-tron have been highlighted as Zacks Bull and Bear of the DayYahoo

Jun-16-26

Jun-16-2612:34PM

Hewlett Packard and M-tron have been highlighted as Zacks Bull and Bear of the DayYahoo

08:00AM

Bear of the Day: M-tron Industries (MPTI)Yahoo

Company

Medical Properties Trust, Inc. functions as a self-managed real estate investment trust (REIT). The company specializes in the financing, acquisition, and construction of healthcare properties, all structured under net-lease agreements. Its extensive property holdings encompass a diverse array of medical establishments, such as rehabilitation centers, extended-stay acute care hospitals, outpatient surgical facilities, hospitals catering to women and children, community and regional general hospitals, medical office complexes, and various other specialized care sites. The trust was established in 2003 by its co-founders, Edward K. Aldag Jr., R. Steven Hamner, Emmett E. McLean, and William Gilliard McKenzie, with its principal offices situated in Birmingham, Alabama.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements

DataTimeframe

Line Item (USD, M)	TTM —	FY 2025 12/31/2025	FY 2024 12/31/2024	FY 2023 12/31/2023	FY 2022 12/31/2022	FY 2021 12/31/2021	FY 2020 12/31/2020	FY 2019 12/31/2019	FY 2018 12/31/2018
Total Revenue	1,000	972	996	—	—	—	—	—	—
Cost of Goods Sold Incl. D&A	40	36	27	—	—	—	—	—	—
Gross Profit	961	936	968	—	—	—	—	—	—
Selling, General and Administrative Excl. Other	121	130	134	—	—	—	—	—	—
Research and Development	0	0	0	—	—	—	—	—	—
Other Operating Expense	271	266	447	—	—	—	—	—	—
Operating Income	570	540	387	—	—	—	—	—	—
Interest Expense	641	510	422	—	—	—	—	—	—
Unusual Expense	—	—	—	—	—	—	—	—	—
Non-Operating Income (Expense)	-58	-267	-2,329	—	—	—	—	—	—
Net Income Before Taxes	-129	-237	-2,364	—	—	—	—	—	—
Income Taxes	-3	39	44	—	—	—	—	—	—
Consolidated Net Income	-126	-277	-2,410	—	—	—	—	—	—
Net Income From Continuing Operations	-124	-276	-2,408	—	—	—	—	—	—
Net Income	-126	-277	-2,410	—	—	—	—	—	—
EPS (Recurring)	-0.21	-0.46	-4.02	—	—	—	—	—	—
EPS (Basic, Before Extraordinaries)	-0.21	-0.46	-4.02	—	—	—	—	—	—
EPS (Diluted)	-0.21	-0.46	-4.02	—	—	—	—	—	—
EBITDA	947	546	-1,488	—	—	—	—	—	—
Other After Tax Adjustments	—	—	—	—	—	—	—	—	—
Stock Option Compensation Expense	—	—	—	—	—	—	—	—	—
Price To Earnings Ratio	—	—	—	—	—	—	—	—	—
Price To Sales Ratio	2.45	3.09	2.38	—	—	—	—	—	—
Gross Margin	96.10	96.30	97.19	—	—	—	—	—	—
Operating Margin	57.00	55.56	38.86	—	—	—	—	—	—
Net Margin	-12.60	-28.50	-241.97	—	—	—	—	—	—
Shares Outstanding	598	601	600	—	—	—	—	—	—
Market Capitalization	2,455	3,005	2,370	—	—	—	—	—	—
Operating Lease Expense	—	—	—	—	—	—	—	—	—

Unlock full historical data

See years of past statements with Premium.

Insider Trading Volume

Insider Trading

Insider	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hooper Rosa Handley	SVP of Operations	Dec 15 '25	Sale	5.00	2,000	10,000	395,182	Dec 16
Stewart Michael G	Director	Nov 19 '25	Sale	5.02	59,000	296,180	157,100	Nov 21
Stewart Michael G	Director	May 05 '25	Sale	5.20	29,000	150,800	216,100	May 05
Hanna James Kevin	Senior VP, Controller & CAO	Mar 05 '25	Buy	5.75	7,411	42,613	372,338	Mar 06
Hanna James Kevin	Senior VP, Controller & CAO	Dec 26 '24	Sale	3.72	11,641	43,305	366,913	Dec 26
Hooper Rosa Handley	SVP of Operations	Dec 23 '24	Sale	3.67	3,000	11,010	356,600	Dec 26
Stewart Michael G	Director	Oct 09 '24	Sale	5.46	32,780	178,979	221,245	Oct 09
Pitman Elizabeth N	Director	Sep 18 '24	Buy	6.01	8,087	48,603	76,740	Sep 19
THOMPSON C REYNOLDS III	Director	Aug 27 '24	Sale	4.38	20,530	89,921	54,637	Aug 27
Pitman Elizabeth N	Director	Aug 15 '24	Sale	4.98	10,025	49,925	68,653	Aug 15
HAMNER R STEVEN	Executive Vice President & CFO	Apr 07 '22	Sale	21.04	285,000	5,996,400	1,961,214	Apr 08
Aldag Edward K JR	Chairman, President & CEO	Mar 30 '22	Sale	21.33	615,000	13,117,950	3,497,206	Apr 01
Stewart Michael G	director:	Mar 10 '22	Sale	20.26	6,000	121,560	214,436	Mar 10
Stewart Michael G	Director	Aug 02 '21	Sale	20.88	4,800	100,224	214,884	Aug 03
Aldag Edward K JR	Chairman, President & CEO	Mar 30 '21	Sale	21.21	710,000	15,059,100	3,251,167	Mar 31

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR

QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.